VRPX - Virpax Pharmaceuticals, Inc.
0.6695
-0.551 -82.226%
Share volume: 2,782,368
Last Updated: 04-03-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.22
-0.55
-0.45%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-14-2024 | 03-03-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 3.302 M | 3.458 M | 1.924 M | 3.395 M | |
| Selling general and admin | 1.689 M | 1.502 M | 780.958 K | 2.288 M | |
| Research and development | 1.613 M | 1.956 M | 1.143 M | 1.107 M | |
| Total expenses | 3.302 M | 3.458 M | 1.924 M | 3.395 M | |
| 4.72% | -44.36% | 76.41% | |||
| Operating income | -3.302 M | -3.458 M | -1.924 M | -3.395 M | |
| Ebit | -3.302 M | -3.439 M | -1.914 M | -3.395 M | |
| Pretax income | -3.220 M | -3.450 M | -2.006 M | -3.390 M | |
| 7.14% | -41.85% | 68.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.220 M | -3.450 M | -2.006 M | -3.390 M | |
| -7.14% | 41.85% | -68.96% |
